In this study, we cataloged TERT genetic alterations (promoter mutations or structural rearrangements), allele-specific promoter methylation patterns, and allele-specific expression levels in 70 metastatic melanomas and 54 cancer cell lines. The gene discussed is TERT; the disease is cancer.